Back to Search Start Over

The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: a randomized controlled trial

Authors :
Orrell, Martin
Yates, Lauren
Leung, Phuong
Kang, Sujin
Hoare, Zoe
Whitaker, Chris
Burns, Alistair
Knapp, Martin
Leroi, Iracema
Moniz-Cook, Esme
Pearson, Stephen
Simpson, Stephen
Spector, Aimee
Roberts, Steven
Russell, Ian
de Waal, Hugo
Woods, Robert T.
Orgeta, Vasiliki
Orrell, Martin
Yates, Lauren
Leung, Phuong
Kang, Sujin
Hoare, Zoe
Whitaker, Chris
Burns, Alistair
Knapp, Martin
Leroi, Iracema
Moniz-Cook, Esme
Pearson, Stephen
Simpson, Stephen
Spector, Aimee
Roberts, Steven
Russell, Ian
de Waal, Hugo
Woods, Robert T.
Orgeta, Vasiliki

Abstract

Background: Cognitive Stimulation Therapy (CST) is a well-established group psychosocial intervention for people with dementia. There is evidence that homebased programmes of cognitive stimulation delivered by family caregivers may benefit both the person and the caregiver. However, no previous studies have evaluated caregiver-delivered CST. This study aimed to evaluate the effectiveness of a home-based, caregiver-led individual Cognitive Stimulation Therapy (iCST) program in (i) improving cognition and quality of life (QoL) for the person with dementia and (ii) mental and physical health (wellbeing) for the caregiver. Methods and Findings: A single-blind, pragmatic randomized trial (RCT) at eight study sites across the UK. The intervention and blinded assessment of outcomes were conducted in participants’ homes. 356 people with mild to moderate dementia and their caregivers recruited from memory services, and community mental health teams. Participants were randomly assigned to iCST (75, 30 minute sessions) or treatment as usual (TAU) control over 25 weeks. iCST sessions consisted of themed activities designed to be mentally stimulating and enjoyable. Caregivers delivering iCST received training and support from an unblind researcher. Primary outcomes were cognition (Alzheimer’s Disease Assessment Scale cognitive [ADAS-Cog]) and self-reported quality of life (QoL) (Quality of Life Alzheimer’s Disease [QoL-AD]) for the person with dementia, and general health status (Short Form-12 [SF-12]) for the caregiver. Secondary outcomes included: quality of the caregiving relationship from the perspectives of the person and of the caregiver (Quality of the Carer Patient Relationships Scale), and health-related QoL (EQ5D) for the caregiver. Intention to treat (ITT) analyses were conducted. At the post-test (26 weeks), there were no differences between the iCST and TAU groups in the outcomes of cognition (MD = -0·55, 95% CI -2·00 to 0·90; p=0·45), and self-reported quality of l

Details

Database :
OAIster
Notes :
doi:10.1371/journal.pmed.1002269
Publication Type :
Electronic Resource
Accession number :
edsoai.on1312878188
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1371.journal.pmed.1002269